论文信息 - A phase I study of veliparib (ABT-888) in combination with weekly carboplatin and paclitaxel in advanced solid malignancies and enriched for triple-negative breast cancer (TNBC). - 字舞流文

A phase I study of veliparib (ABT-888) in combination with weekly carboplatin and paclitaxel in advanced solid malignancies and enriched for triple-negative breast cancer (TNBC).

A. Chen | H. Tawbi | V. Giranda | L. Appleman | E. Chu | S. Puhalla | Yan Lin | J. Beumer | James J. Lee | C. Belani | R. Stoller | S. Pahuja | Fei Ding | Jing Yu | S. Shepherd